Stay updated on Zimura for AMD: Phase 3 Clinical Trial

Sign up to get notified when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zimura for AMD: Phase 3 Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-07T18:32:24.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new bibliographic entry was added to Publications: Khanani et al. Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial. The prior entry with slightly different capitalization and wording (2-year efficacy and safety results from the GATHER2 phase 3 trial) was removed.
    Difference
    0.0%
    Check dated 2026-02-21T06:33:06.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    This change reflects minor version updates: addition of Revision: v3.4.2 and removal of Revision: v3.4.1, with no changes to study details, eligibility, outcomes, or visible page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T04:30:31.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision note updated from v3.4.0 to v3.4.1; this is a minor version update with no substantive impact on study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T00:01:43.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    UI changes add Show glossary and Hide glossary options and update QC fields (Last Update Submitted that Met QC Criteria, Last Update Posted) and the revision label (Revision: v3.4.0); no core study content or eligibility criteria are changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-23T18:24:27.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.3.4, was added, and the previous Revision: v3.3.3 was removed.
    Difference
    0.0%
    Check dated 2026-01-16T12:00:50.000Z thumbnail image

Stay in the know with updates to Zimura for AMD: Phase 3 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.